Laura W Dillon

17PUBLICATIONS
76CO-AUTHORS
Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 04, 2026
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

|Feb 06, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.

Niveditha Ravindra, Justin Lack, Clifton L Dalgard

|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

|Jul 09, 2025
Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.

Gege Gui, Molly A Bingham, Julius R Herzog

|Feb 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.

Athalia R Pyzer, Laura W Dillon, Elad Sharon

|Nov 06, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Gege Gui, Niveditha Ravindra, Pranay S Hegde

Pageof 3

Frequent Collaborators

13 joint publications

Christopher S Hourigan

6 joint publications

Niveditha Ravindra

4 joint publications

Jeffery J Auletta

4 joint publications

Marcos J G De Lima